{"id":"https://openalex.org/W3214136235","doi":"https://doi.org/10.1158/1538-7445.panca21-po-079","title":"Abstract PO-079: Proteomic profiling reveals subtype specific kinase expression in pancreatic cancer","display_name":"Abstract PO-079: Proteomic profiling reveals subtype specific kinase expression in pancreatic cancer","publication_year":2021,"publication_date":"2021-11-15","ids":{"openalex":"https://openalex.org/W3214136235","doi":"https://doi.org/10.1158/1538-7445.panca21-po-079","mag":"3214136235"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.panca21-po-079","doi":"https://doi.org/10.1158/1538-7445.panca21-po-079","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.panca21-po-079","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013686582","display_name":"Yi Xu","orcid":"https://orcid.org/0000-0003-2720-0005","observed_orcids":["https://orcid.org/0000-0003-2720-0005"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi Xu","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074104547","display_name":"Michael P. East","orcid":"https://orcid.org/0000-0002-1994-6117","observed_orcids":["https://orcid.org/0000-0002-1994-6117"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael East","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006661829","display_name":"Ashley Morrison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley Morrison","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153059550","display_name":"Gabriela Herrera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela Herrera","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084896196","display_name":"Laura Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Peng","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047612906","display_name":"Gary L. Johnson","orcid":"https://orcid.org/0000-0003-2867-0551","observed_orcids":["https://orcid.org/0000-0003-2867-0551"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Johnson","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065098287","display_name":"Jen Jen Yeh","orcid":"https://orcid.org/0000-0003-2542-6211","observed_orcids":["https://orcid.org/0000-0003-2542-6211"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jen Jen Yeh","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"22_Supplement","first_page":"PO","last_page":"079"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/kinome","display_name":"kinome","score":0.48100000619888306},{"id":"https://openalex.org/keywords/tumor-subtypes","display_name":"tumor subtypes","score":0.6909999847412109},{"id":"https://openalex.org/keywords/basal-like-subtype","display_name":"basal-like subtype","score":0.7940000295639038},{"id":"https://openalex.org/keywords/classical-subtype","display_name":"classical subtype","score":0.9919999837875366},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8450000286102295},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.6790000200271606},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.9350000023841858},{"id":"https://openalex.org/keywords/mitogen-activated-protein-kinase","display_name":"mitogen-activated protein kinase","score":0.8259999752044678},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5130000114440918},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.9914480447769165},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6959899663925171},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6770445704460144},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6354106664657593},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.47038355469703674},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.4655521512031555},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4316742718219757},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3750881850719452},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29889389872550964},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2651033103466034},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.1290070116519928},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11256459355354309}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.panca21-po-079","doi":"https://doi.org/10.1158/1538-7445.panca21-po-079","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.panca21-po-079","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4309192771","https://openalex.org/W7161963667","https://openalex.org/W4405084219","https://openalex.org/W3104378422","https://openalex.org/W4395045562","https://openalex.org/W6977666310","https://openalex.org/W2411389177","https://openalex.org/W2338583434","https://openalex.org/W2740138378","https://openalex.org/W6976520527"],"abstract_inverted_index":{"Abstract":[0],"Pancreatic":[1,290],"adenocarcinoma":[2],"(PDAC)":[3],"remains":[4],"an":[5],"extremely":[6],"lethal":[7],"disease":[8],"with":[9,203],"few":[10],"effective":[11],"therapeutic":[12],"options.":[13],"Targeted":[14],"therapy":[15,107],"development":[16],"has":[17],"remained":[18],"largely":[19],"unsuccessful":[20],"due":[21],"to":[22,55,86,97,106,130,195,234,248],"complex":[23],"tumor":[24,42,74,79,123,243],"heterogeneity":[25],"and":[26,47,52,76,92,102,122,141,160,174,209,220],"better":[27],"molecular":[28,41],"indicators":[29],"of":[30,72,114,149,169,192,205,283],"response":[31,54,194,247],"are":[32,50],"urgently":[33],"needed.":[34],"We":[35,57],"have":[36,58],"previously":[37],"identified":[38,118],"two":[39],"distinct":[40,225],"subtypes":[43,80],"in":[44,81,108,152,172,251,277],"PDAC,":[45],"basal-like":[46,140,219],"classical,":[48],"which":[49],"prognostic":[51],"dictate":[53],"chemotherapy.":[56],"also":[59],"developed":[60],"a":[61],"patient":[62,73],"derived":[63],"xenograft":[64],"(PDX)":[65],"mouse":[66],"model":[67],"that":[68,218,228],"maintains":[69],"the":[70,284],"integrity":[71],"biology":[75],"recapitulates":[77],"primary":[78],"vivo.":[82],"Here,":[83],"we":[84],"aim":[85],"utilize":[87],"multiplexed":[88],"kinase":[89,100,134,155,158,211,235,238,275],"inhibitor":[90,239],"beads":[91],"quantitative":[93],"mass":[94],"spectrometry":[95],"(MIB-MS)":[96],"determine":[98],"baseline":[99],"expression":[101,135,148,168,180,187,276],"adaptive":[103],"kinome":[104,193,201,226],"responses":[105],"PDAC":[109],"PDX":[110],"tumors.":[111,143],"A":[112],"total":[113],"381":[115],"kinases":[116,125,150,170,208],"were":[117,126,137],"across":[119],"all":[120],"samples":[121],"specific":[124,232,274],"isolated":[127],"by":[128,184,198],"alignment":[129],"human":[131],"peptides.":[132],"Distinct":[133],"profiles":[136,227],"observed":[138],"for":[139],"classical":[142,221],"Basal-like":[144],"tumors":[145,165,223],"showed":[146,166],"high":[147],"involved":[151,171],"receptor":[153],"tyrosine":[154],"activity,":[156,159],"MAP":[157,210],"clathrin-dependent":[161],"endocytosis.":[162],"Classical":[163],"subtype":[164,222,231,244,273],"increased":[167],"metabolism":[173],"cytoskeletal":[175],"regulatory":[176],"kinases.":[177],"Differential":[178],"protein":[179],"was":[181],"further":[182],"validated":[183],"differential":[185],"gene":[186],"using":[188],"RNAseq.":[189],"MIB":[190],"profiling":[191,271],"EGFR":[196],"inhibition":[197],"erlotinib":[199],"indicated":[200],"reprogramming":[202],"upregulation":[204],"microtubule":[206],"associated":[207],"family":[212],"members.":[213],"Overall,":[214],"these":[215],"results":[216],"suggest":[217],"exhibit":[224],"present":[229],"possible":[230],"vulnerabilities":[233],"inhibition.":[236],"Stratifying":[237],"therapies":[240,250],"based":[241],"on":[242,289],"could":[245],"improve":[246],"targeted":[249],"PDAC.":[252],"Citation":[253],"Format:":[254],"Yi":[255],"Xu,":[256],"Michael":[257],"East,":[258],"Ashley":[259],"Morrison,":[260],"Gabriela":[261],"Herrera,":[262],"Laura":[263],"Peng,":[264],"Gary":[265],"Johnson,":[266],"Jen":[267,268],"Yeh.":[269],"Proteomic":[270],"reveals":[272],"pancreatic":[278],"cancer":[279],"[abstract].":[280],"In:":[281],"Proceedings":[282],"AACR":[285],"Virtual":[286],"Special":[287],"Conference":[288],"Cancer;":[291],"2021":[292],"Sep":[293],"29-30.":[294],"Philadelphia":[295],"(PA):":[296],"AACR;":[297],"Cancer":[298],"Res":[299],"2021;81(22":[300],"Suppl):Abstract":[301],"nr":[302],"PO-079.":[303]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2021-11-22T00:00:00"}